1-6 of 6
Anja Pedersen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

TP53 mutations identify younger mantle cell lymphoma patients who do not benefit from intensive chemoimmunotherapy

Clinical Trials & Observations
Christian W. Eskelund, Christina Dahl, Jakob W. Hansen, Maj Westman, Arne Kolstad, Lone B. Pedersen, Carmen P. Montano-Almendras, Simon Husby, Catja Freiburghaus, Sara Ek, Anja Pedersen, Carsten Niemann, Riikka Räty, Peter Brown, Christian H. Geisler, Mette K. Andersen, Per Guldberg, Mats Jerkeman, Kirsten Grønbæk
Journal: Blood
Blood (2017) 130 (17): 1903–1910.
https://doi.org/10.1182/blood-2017-04-779736
Published: 2017
Includes: Supplemental data
Journal Articles

miR-18b overexpression identifies mantle cell lymphoma patients with poor outcome and improves the MIPI-B prognosticator

Simon Husby, Ulrik Ralfkiaer, Christian Garde, Roza Zandi, Sara Ek, Arne Kolstad, Mats Jerkeman, Anna Laurell, Riikka Räty, Lone B. Pedersen, Anja Pedersen, Mats Ehinger, Christer Sundström, Marja-Liisa Karjalainen-Lindsberg, Jan Delabie, Erik Clasen-Linde, Peter Brown, Jack B. Cowland, Christopher T. Workman, Christian H. Geisler, Kirsten Grønbæk
Journal: Blood
Blood (2015) 125 (17): 2669–2677.
https://doi.org/10.1182/blood-2014-06-584193
Published: 2015
Includes: Supplemental data
Journal Articles

Diagnostic Tumor Mirna Profiling Predicts Molecular Relapse in Mantle Cell Lymphoma Patients Prospectively Followed for Minimal Residual Disease. Results from the Nordic MCL2-3 Trials

Simon Husby, MD, Lone Bredo Pedersen, Ulrik Ralfkiær, PhD-student, Christian Garde, Sara Ek, Arne Kolstad, MD PhD, Mats Jerkeman, MD PhD, Anna Laurell, Riikka Räty, Anja Pedersen, Christer Sundström, Marja-Liisa Karjalainen-Lindsberg, Jan Delabie, MD PhD, Erik Clasen-Linde, MD, Christopher Workman, PhD, Christian H Geisler, Kirsten Grønbæk, MD DMSc
Journal: Blood
Blood (2014) 124 (21): 2994.
https://doi.org/10.1182/blood.V124.21.2994.2994
Published: 2014
Journal Articles

Diffuse Large B-Cell Lymphoma With Combined TP53 mutation and MIR34A methylation: Another “double hit” Lymphoma With Very Poor Outcome?

Fazila Asmar, MD, Christoffer Hother, MD, PhD, Gorjan Kulosman, MD, Marianne B. Treppendahl, MD PhD, Helene Myrtue Nielsen, MSc, Ralfkiaer Ulrik, MSc, Anja Pedersen, Michael B. Møller, MD, DMSc, Elisabeth Ralfkiaer, MD, DMSc, Peter de Nully Brown, MD, Kirsten Grønbæk, MD, DMSc
Journal: Blood
Blood (2013) 122 (21): 83.
https://doi.org/10.1182/blood.V122.21.83.83
Published: 2013
Journal Articles

miR34s in Normal and Malignant B-Cells: miR34A Plays a Dominant Role in Normal B-Cells, and aggressive Diffuse Large B-Cell Lymphoma Carry Combined Lesions of TP53, MIR34A , and MIR34B/C

Christoffer Hother, MD, Fazila Asmar, MD, Gorjan Kulosman, MD, Marianne B. Treppendahl, MD, Ditte Reker, Ulrik Ralfkiaer, MSc, Anja Pedersen, Michael B. Møller, MD, DMSc, Peter De Nully Brown, Kirsten Grønbæk, MD, DMSc
Journal: Blood
Blood (2012) 120 (21): 296.
https://doi.org/10.1182/blood.V120.21.296.296
Published: 2012
Journal Articles

TET2 mutations in Diffuse Large B-Cell Lymphoma: The Role of TET2 in the Regulation of Methylation Patterns at TET2 Target Genes

Fazila Asmar, Jesper Christensen, Jens V Johansen, Anders Blåbjerg, Anja Pedersen, Christoffer Hother, Ulrik Ralfkiaer, Kristian Helin, Kirsten Grønbæk
Journal: Blood
Blood (2011) 118 (21): 1364.
https://doi.org/10.1182/blood.V118.21.1364.1364
Published: 2011